HUMAN PAPILLOMAVIRUS (HPV) VACCINE’S SIDE EFFECTS.

• Facebook
• X
• Line

The HPV vaccine protects against Human Papillomavirus, which can cause several types of cancer. Millions of people have received this vaccination, and many parents wonder about the potential side effects.

Most people who get the HPV vaccine have no side effects at all, and when side effects do occur, they are usually mild and temporary. Over 100 million doses have been administered in the U.S., and extensive studies show a reassuring safety profile.

The most commonly reported side effects include pain at the injection site, mild headaches, or fatigue. Serious side effects are very rare. Understanding these possible reactions helps families make informed decisions about this important vaccination.

KEY TAKEAWAYS

• The HPV vaccine has a proven safety profile, with side effects that are mostly mild and temporary.
• Common side effects are limited to pain at the injection site, headaches, and mild fatigue.
• Serious side effects are extremely rare and are continuously tracked by monitoring systems.

CONTENTS

1. COMMON SIDE EFFECTS OF THE HPV VACCINE

• INJECTION SITE REACTIONS
• FATIGUE AND HEADACHE
• FEVER AND MALAISE
• NAUSEA AND DIZZINESS

2. RARE AND SERIOUS SIDE EFFECTS

• ALLERGIC REACTIONS AND ANAPHYLAXIS
• NEUROLOGICAL EVENTS
• MUSCLE AND JOINT PAIN
• VACCINE SAFETY MONITORING

Most people tolerate HPV vaccines like Gardasil and Cervarix well. However, more than 1 in 10 people develop mild discomfort at the injection site or a headache.

Pain is the most common side effect following the HPV vaccination. More than 80 percent of recipients report pain at the injection site.

The pain usually begins a few hours after the vaccination and typically lasts for 1 to 3 days.

Redness and swelling occur in about half of all patients. These reactions indicate that the immune system is responding to the vaccine.

The affected area may become warm and feel firm. Cool compresses can help alleviate the discomfort.

With Gardasil 9, injection site reactions are slightly more common than with older HPV vaccines, but the symptoms resolve just as quickly.

Headaches develop in about 1 in 10 people after the HPV vaccination. They usually occur on the day of the vaccination or the following day.

The headaches are typically mild to moderate in severity and rarely last longer than 24 to 48 hours.

Fatigue is another common reaction to HPV vaccines. Many people feel exhausted on the day of the vaccination or the day after.

This fatigue is normal and shows the body’s immune response. Adequate sleep and rest help with recovery.

Both headaches and fatigue can occur after any dose of the HPV vaccine series. The second dose does not necessarily cause more severe symptoms.

A mild fever develops in about 1 in 20 people after the HPV vaccination. The body temperature usually rises by only 1 to 2 degrees.

The fever typically begins 6 to 12 hours after the vaccination and rarely lasts longer than 24 hours.

General malaise can manifest as a feeling of weakness or body aches. These symptoms are signs that the body is producing antibodies.

Adolescents develop fever more frequently than adults after HPV vaccinations. With Gardasil 9, fever is slightly more common than with other HPV vaccines.

A high fever above 39°C (102.2°F) is very rare. Patients should consult a doctor for a persistent fever.

Nausea occurs in about 4 to 7 percent of those vaccinated against HPV. It usually begins a few hours after the injection and subsides quickly.

The nausea is normally mild and rarely leads to vomiting. Light meals and adequate fluid intake help with the discomfort.

Dizziness develops in about 4 percent of recipients. It often occurs along with nausea or headaches.

The dizziness can begin immediately after the vaccination or a few hours later. Sitting or lying down quickly relieves the symptoms.

These symptoms are documented for all HPV vaccines. The CDC and VAERS report similar frequencies for nausea and dizziness following the Human Papillomavirus Vaccine.

Serious side effects following an HPV vaccination are extremely rare but do occasionally occur. Allergic reactions, such as anaphylaxis, and neurological events are recorded and investigated by monitoring systems.

Anaphylaxis is the most severe form of an allergic reaction to the HPV vaccine. This life-threatening reaction occurs in fewer than 1 in 1 million vaccine doses.

Symptoms of anaphylaxis usually develop within minutes of vaccination. The signs include:

• Severe shortness of breath
• Swelling of the face and throat
• Rapid pulse
• A rash over the entire body
• Dizziness or loss of consciousness

Hypersensitivity reactions are milder than anaphylaxis but should still be taken seriously. These can include hives, significant swelling, or persistent nausea.

Individuals with known severe allergies to vaccine components should not receive the HPV vaccine. All vaccination sites are prepared for such emergencies and can provide immediate treatment.

Guillain-Barré Syndrome (GBS) is a rare neurological disorder that can occur after various vaccinations. In GBS, the immune system attacks the body’s own nerves.

Studies show no definitive link between the HPV vaccine and GBS. The FDA and CDC continuously monitor such cases.

Acute Disseminated Encephalomyelitis (ADEM) is another rare neurological complication. This condition causes inflammation in the brain and spinal cord.

Other reported neurological events include:

• Multiple sclerosis-like symptoms
• Transverse Myelitis (inflammation of the spinal cord)
• Motor neuron diseases

However, most studies find no causal relationship between these conditions and the HPV vaccine.

Arthralgia (joint pain) is occasionally reported after HPV vaccinations. This pain can last for weeks or months.

Affected individuals report:

• Stiff joints in the morning
• Pain in the hands and feet
• Muscle aches with no apparent cause

The frequency of chronic joint pain after HPV vaccination is unclear. Controlled studies show similar rates in both vaccinated and unvaccinated individuals.

For persistent muscle or joint pain, affected individuals should consult a doctor. A thorough examination can rule out other causes.

The Vaccine Adverse Event Reporting System (VAERS) collects reports of side effects following vaccinations. Doctors and patients can report events directly.

The FDA and CDC regularly analyze VAERS data for safety signals. Since 2006, over 270 million doses of the HPV vaccine have been administered.

Additional monitoring systems include:

• Vaccine Safety Datalink (VSD)
• Clinical Immunization Safety Assessment (CISA)
• Post-marketing studies by manufacturers

These systems allow for the rapid detection of rare side effects. Continuous monitoring confirms the positive benefit-risk profile of the HPV vaccine.